Palani Santhosh has filed 6 insider transactions across 2 companies since March 2024.
Most recent transaction: a grant/award of 45867 shares of Pyxis Oncology, Inc. ($PYXS) on March 24, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 24, 2026 | Pyxis Oncology, Inc. | $PYXS | Palani Santhosh | Not found | A | Stock Option (Right to Buy) | 45867 | $0.00 | 45,867.0000 | 62,557,386 | 9999.99% | 0.07% |
| June 13, 2025 | Acrivon Therapeutics, Inc. | $ACRV | Palani Santhosh | Not found | A | Stock Option (Right to Buy) | 20275 | $0.00 | 20,275.0000 | 33,791,817 | 9999.99% | 0.06% |
| March 31, 2025 | Pyxis Oncology, Inc. | $PYXS | Palani Santhosh | Not found | A | Stock Option (Right to Buy) | 36979 | $0.98 | 36,979.0000 | 58,445,765 | 9999.99% | 0.06% |
| June 7, 2024 | Pyxis Oncology, Inc. | $PYXS | Palani Santhosh | Not found | A | Common Stock | 6000 | $0.00 | 6,000.0000 | 39,904,603 | 9999.99% | 0.02% |
| March 12, 2024 | Pyxis Oncology, Inc. | $PYXS | Palani Santhosh | Not found | A | Stock Option (Right to Buy) | 69760 | $0.00 | 69,760.0000 | 39,904,603 | 9999.99% | 0.17% |
| March 4, 2024 | Acrivon Therapeutics, Inc. | $ACRV | Palani Santhosh | Not found | A | Stock Option (Right to Buy) | 32500 | $0.00 | 32,500.0000 | 22,078,190 | 9999.99% | 0.15% |